• Govind Singh
• Tanu Shiri
• Akash Kumar
• Dr. Sourabh Jain

Hybridoma technology are mostly used for the innate functions of both immune cells and testing of the cancer, with the help of production of Hybridoma cells, which are regularly generate the monoclonal antibodies specific to antigen of interest. Generating of the Hybridoma cells with the help of Hybridoma technology, and the helping of this technology are formed of the B-lymphocytes must be somatically fused with myeloma cells. Some scientist has been developed a new Hybridoma technology and this is used for the involves preselection of B-lymphocytes with target antigens based on the immunoglobulin receptors and the helping of the electrical pulses are fused of the B-cells-myeloma complexes, some monoclonal antibodies formed as anti-CEA, Ca1 and HMEG-2, which are used for the search of the malignant disease. The advancement methodology is formed with the help of this technology; may be applicable to simultaneous production of monoclonal antibodies, multitargeting and stereospecific targeting, termed B-cell targeting, selective production of stereospecific monoclonal antibodies for clinical purposes.

Hybridoma cells, CEA and B-lymphocytes.

"HYBRIDOMA TECHNOLOGY USED FOR THE SCANNING OF VARIOUS DISEASE & CURE WITH THE HELP OF MABS.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.8, Issue 5, page no.b397-b403, May-2021, Available :http://www.jetir.org/papers/JETIR2105181.pdf

"HYBRIDOMA TECHNOLOGY USED FOR THE SCANNING OF VARIOUS DISEASE & CURE WITH THE HELP OF MABS.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 5, page no. ppb397-b403, May-2021, Available at : http://www.jetir.org/papers/JETIR2105181.pdf